>>> US Gapping down




Gapping down
In reaction to disappointing earnings/guidance
: LINE -33.7%, VRX -17.9%, DCO -7.6%, MNKD -6.5%, (COO Juergen Martens resigns, Michael Castagna named Chief Commercial Officer, effective immediately ), ONTY -5.2%, NAVB -4.3%, TTEC -4%, MOMO -3.5%, FSM -2.6%, CFRX -1.7%, JMBA -1.6%, KANG -1%, LUK -0.9%, (Jefferies reports challenged Q1 results) PWR -0.8%, (appoints COO Earl Austin Jr to succeed Jim O'Neil as CEO effective immediately, reaffirms 2016 growth strategy & outlook), JASO -0.8%

M&A news: PRTY -2.7% (Acquires Festival SA for ~$5 mln)

Select EU financial related names showing weakness: SAN -3.4%, CS -3.1%, DB -2.7%, LYG -2%, BCS -1.4%, ING -1.2%, HSBC -0.9%

Select metals/mining stocks trading lower: BBL -7.1%, MT -5%, FCX -4.7%, AKS -3.7%, CLF -3.3%, X -3%, AA -1.4%

Select oil/gas related names showing early weakness: WLL -6%, SDRL -4.9%, PBR -4.6%, CHK -3.9%, BP -2.5%, MRO -2.5%, RIG -1.4%, TOT -1.4%

Other news: IMMU -15.1% (To terminate the Phase 3 PANCRIT-1 trial with yttrium-90-labeled clivatuzumab tetraxetan in patients with metastatic pancreatic cancer), ALR -8.2% (will be unable to file its 2015 Form 10-K within the extension period, discloses receipt of a grand jury subpoena from the DOJ), TCON -5.4% ( initiates phase 1B study of TRC105 in patients with lung cancer), NVIV -4.6% (commences an underwritten public offering of common stock for unspecified amount), CNX -3.9% (Moody's downgrades CONSOL (CNX) to B2 with outlook negative and Moody's downgrades Natural Resource Partners (NRP) to B3 with outlook negative), CBPX -3% ( announces 4.5 mln share secondary common stock offering by selling shareholders & 900,000 share repurchase), ZYNE -2.5% (following 150% surge higher Monday), GLOG -1.7% (files for $600 mln mixed securities shelf offering )

Analyst comments: DDD -8% (downgraded to Underweight from Neutral at JP Morgan), BHP -6.3% (downgraded to Underperform from Neutral at Macquarie), RIO -4.8% (downgraded to Equal Weight from Overweight at Morgan Stanley), HIBB -3.3% (downgraded to Sell from Neutral at Goldman), AZN -2.3% (downgraded to Hold from Buy at Jefferies), TIF -1.8% (downgraded to Neutral from Buy at Citigroup)